Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Innovations in IO Topic Center

Featured

Altan Ahmed, MD, Moffitt Cancer Center
Videos
Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma
10/16/2024
Altan Ahmed, MD, discusses percutaneous hepatic perfusion as a treatment option for patients with metastatic uveal melanoma.
Altan Ahmed, MD, discusses percutaneous hepatic perfusion as a treatment option for patients with metastatic uveal melanoma.
Altan Ahmed, MD, discusses...
10/16/2024
IO Learning
Ripal Gandhi, MD, FSVM
Videos
Interventional Approaches for Locally Advanced Pancreatic Cancer
10/15/2024
Ripal Gandhi, MD, FSVM, discusses the new and upcoming approaches for treating locally advanced pancreatic cancer.
Ripal Gandhi, MD, FSVM, discusses the new and upcoming approaches for treating locally advanced pancreatic cancer.
Ripal Gandhi, MD, FSVM,...
10/15/2024
IO Learning
Osman Ahmed, MD, University of Chicago Medicine
Videos
Intratumor Injections in Interventional Oncology
10/15/2024
Osman Ahmed, MD, discusses the where interventional radiologists might fit in when it comes to intratumor injections for oncology patients.
Osman Ahmed, MD, discusses the where interventional radiologists might fit in when it comes to intratumor injections for oncology patients.
Osman Ahmed, MD, discusses the...
10/15/2024
IO Learning
Govindarajan Narayanana, MD, Miami Cardiac and Vascular Disease Institute
Podcasts
Irreversible Electroporation for Pancreatic Cancer
09/26/2024
Elena Violari, MD, RPVI, discusses irreversible electroporation for pancreatic cancer with Govindarajan Narayanan, MD, in the latest episode of the SIO Corner podcast.
Elena Violari, MD, RPVI, discusses irreversible electroporation for pancreatic cancer with Govindarajan Narayanan, MD, in the latest episode of the SIO Corner podcast.
Elena Violari, MD, RPVI,...
09/26/2024
IO Learning
News
Novel Endovascular Robotic Surgical System Reaches Midpoint of Pivotal Clinical Trial
09/20/2024
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY®...
09/20/2024
IO Learning
News
Histotripsy Demonstrates Technical Success, Safety for Primary and Metastatic Liver Tumors
09/04/2024
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the...
09/04/2024
IO Learning
Edward Kim, MD
Videos
Previewing the 2024 Symposium on Clinical Interventional Oncology Agenda
08/28/2024
Edward Kim, MD, shares what he is most excited about at this year’s upcoming Symposium on Clinical Interventional Oncology.
Edward Kim, MD, shares what he is most excited about at this year’s upcoming Symposium on Clinical Interventional Oncology.
Edward Kim, MD, shares what he...
08/28/2024
IO Learning
Nadine Abi-Jaoudeh, MD, University of California, Irvine
Videos
What to Look Forward to at This Year’s Symposium on Clinical Interventional Oncology
08/28/2024
Nadine Abi-Jaoudeh, MD, shares what she is most excited about at this year’s Symposium on Clinical Interventional Oncology.
Nadine Abi-Jaoudeh, MD, shares what she is most excited about at this year’s Symposium on Clinical Interventional Oncology.
Nadine Abi-Jaoudeh, MD, shares...
08/28/2024
IO Learning
Ripal Gandhi, MD, FSVM
Videos
Program Highlights at This Year’s Symposium on Clinical Interventional Oncology
08/28/2024
Ripal Gandhi, MD, FSVM, shares what he is most excited about at this year’s Symposium on Clinical Interventional Oncology.
Ripal Gandhi, MD, FSVM, shares what he is most excited about at this year’s Symposium on Clinical Interventional Oncology.
Ripal Gandhi, MD, FSVM, shares...
08/28/2024
IO Learning
Premal Trivedi, MD; Junaid Raja, MD, MSPH; John Smirniotopoulos, MD
Podcasts
Cholangioscopy: What Interventional Oncologists Need to Know
08/21/2024
In the latest SIO Corner podcast, Junaid Raja, MD, MSPH, John Smirniotopoulos, MD, and Premal Trivedi, MD, join our host, Elena Violari, MD, RPVI to discuss the ins and outs of cholangioscopy.
In the latest SIO Corner podcast, Junaid Raja, MD, MSPH, John Smirniotopoulos, MD, and Premal Trivedi, MD, join our host, Elena Violari, MD, RPVI to discuss the ins and outs of cholangioscopy.
In the latest SIO Corner...
08/21/2024
IO Learning
Premal Trivedi, MD; Junaid Raja, MD, MSPH; John Smirniotopoulos, MD
Podcasts
Cholangioscopy: What Interventional Oncologists Need to Know
08/21/2024
In the latest SIO Corner podcast, Junaid Raja, MD, MSPH, John Smirniotopoulos, MD, and Premal Trivedi, MD, join our host, Elena Violari, MD, RPVI to discuss the ins and outs of cholangioscopy.
In the latest SIO Corner podcast, Junaid Raja, MD, MSPH, John Smirniotopoulos, MD, and Premal Trivedi, MD, join our host, Elena Violari, MD, RPVI to discuss the ins and outs of cholangioscopy.
In the latest SIO Corner...
08/21/2024
IO Learning

Presentations

Dr de Baere
Human Intratumoral Injections: Rationale and Technique
02/08/2022
Dr Chick
Endoscopy in Image-Guided Interventions for the IO/IR
02/08/2022
Dr Alban
Inadequate Future Liver Remnant: Hepatic Venous Deprivation with Simultaneous Portal Vein Embolization and Hepatic Vein Embolization
02/08/2022
Dr Raj
Pancreas: Irreversible Electroporation (IRE)
02/08/2022
Dr de Baere
Local Immunotherapy: The Role of IR
02/08/2022
Dr Bryce
Locoregional Treatment of Breast Cancer
02/08/2022
Dr Afshin Gangi
Interventional Neuro-Oncology: The Next Frontier
02/08/2022
Dr Bhatia
IR in Prostate Cancer
02/08/2022
My Approach to Metastatic Breast Cancer
02/04/2022
My Approach to Metastatic Colorectal Cancer
02/04/2022
Dr. David S. Wang
CIO Presentation
HCC: Year in Review With Dr. David S. Wang
11/09/2023
During CIO 2023, David S. Wang, MD, clinical associate professor, radiology at Stanford Medicine summarized key developments in the management of hepatocellular carcinoma (HCC) over the past year.
During CIO 2023, David S. Wang, MD, clinical associate professor, radiology at Stanford Medicine summarized key developments in the management of hepatocellular carcinoma (HCC) over the past year.
During CIO 2023, David S. Wang,...
11/09/2023
IO Learning
Callstrom CIO
Musculoskeletal Oncologic Interventions: 2022 Year in Review
Matthew Callstrom, MD, PhD presents notable 2022 studies on musculoskeletal interventions at the Symposium on Clinical Interventional Oncology.
01/06/2023
Ahmed CIO Video
Renal Ablation: 2022 Year in Review
Muneeb Ahmed, MD, FSIR presents notable 2022 studies on renal ablation at the Symposium on Clinical Interventional Oncology.
01/06/2023
Robert Suh
Lung Ablation: 2022 Year in Review
Robert Suh, MD presents notable 2022 studies on lung ablation at the Symposium on Clinical Interventional Oncology.
01/06/2023
Ganguli CIO
Y90 Update on Metastatic Disease: 2022 Year in Review
Suvranu Ganguli, MD, FSIR presents notable 2022 studies on Y-90 for metastatic disease at the Symposium on Clinical Interventional Oncology.
01/06/2023
Tabori CIO
Y90: 2022 Year in Review
Nora Tabori, MD presents notable Y-90 studies at the Symposium on Clinical Interventional Oncology in 2022.
01/06/2023
Dan Brown
Liver Metastatic Disease: 2022 Year in Review
Daniel Brown, MD, FSIR reviews noteworthy 2022 studies on liver metastatic disease at the Symposium on Clinical Interventional Oncology.
01/04/2023
Riad Salem, MD, MBA
HCC: 2022 Year in Review
Riad Salem, MD, MBA presents notable studies from 2022 at the Symposium on Clinical Interventional Oncology.
01/01/2023
Dr Abdel Aal
HCC Treatment Complicated by Pneumothorax
02/17/2022
Dr Prologo
Cement Placement Complicated by Extra Vertebral Body
02/17/2022

Abstracts

CIO 2022-4 Preoperative Endovascular Embolization of Intracranial Meningiomas
Purpose: The purpose is to report on technical considerations involved in preoperative embolization of intracranial meningiomas. We present four cases to highlight the associated vascular...
10/18/2022
CIO 2022-12 Uterine Artery Embolization in the Treatment of Postpartum Uterine Hemorrhage: A Single-Center Experience in India
Purpose: To evaluate the clinical effectiveness and safety of uterine artery embolization (UAE) in the treatment of patients with primary postpartum hemorrhage (PPH), secondary PPH, and P...
10/18/2022
CIO 2022-13 Role of Embolization in Acquired Uterine Vascular Malformations: A Single-Center Study in India
Purpose: To determine the efficacy of uterine artery embolization (UAE) in patients with bleeding acquired uterine arteriovenous malformations (AVMs).
10/18/2022
CIO 2022-15 Uterine Artery Embolization: An Interventional Aid
Purpose: Fibroids are the commonest benign lesions of the uterus. They present with bleeding per vagina in majority of the cases. Surgical treatment consists of hysterectomy or myomectomy...
10/18/2022
CIO 2022-17 Preoperative Embolization in Carotid Body Tumors: A Single-Center Experience in India
Purpose: The purpose of this study is to compare the efficiency of preoperative embolization on vascular rupture rates during surgery in 260 patients within two groups.
10/18/2022
CIO 2022-18 Role of Splenic Artery Embolization in the Management of Various Splenic Pathologies
Purpose: To evaluate technical and clinical success, complications of splenic artery embolization in management of different splenic pathologies.
10/18/2022
CIO 2022-19 Embolization of the Lingual Artery in Transoral Robotic Surgery for Management of Recurrent Tongue Carcinomas
Purpose: The incidence of oropharyngeal carcinoma has been on the rise in recent decades. About 30% of patients who undergo definitive chemoradiation as the initial treatment present with...
10/18/2022
CIO 2021-7 Recent Advances and Future Directions in Locoregional Therapy for Colorectal Cancer with Liver Metastasis
Purpose: Colon cancer is the third most common cancer worldwide, and half of patients with colon cancer will develop liver metastasis. In the past decade, a number of locoregional approac...
11/15/2021
CIO 2021-8 Selective Internal Radiation Therapy of Metastatic Breast Cancer to the Liver: A Meta-analysis
Purpose: To conduct a meta-analysis to assess the safety and efficacy of yttrium-90 transarterial radioembolization (TARE) in treating breast cancer patients with hepatic metastasis ...
11/15/2021
CIO 2021-9 Efficacy of prostate artery embolization in low and high risk prostate cancer patients
Purpose: Patients diagnosed with prostate cancer (PCa) are usually put into low and high risk groups. Patients in the low risk category often have a choice of undergoing Active Surveillan...
11/15/2021
Ebstesam Nafie
CIO2023 Highlights
A Case Report of Successful Treatment of Metastatic Liposarcoma with Pulsed Electric Fields
12/14/2023
Ebstesam Nafie discusses her CIO2023 abstract, "CIO 2023-24 A Case Report of Successful Treatment of Metastatic Liposarcoma with Pulsed Electric Fields."
Ebstesam Nafie discusses her CIO2023 abstract, "CIO 2023-24 A Case Report of Successful Treatment of Metastatic Liposarcoma with Pulsed Electric Fields."
Ebstesam Nafie discusses her...
12/14/2023
IO Learning
Palliative Ablation and Kyphoplasty for a Suspected Metastatic Fracture
CIO2023 Highlights
Palliative Ablation and Kyphoplasty for a Suspected Metastatic Fracture
11/30/2023
Hanna Thompson discusses her CIO2023 abstract, "CIO 2023-30 Palliative Ablation and Kyphoplasty for a Suspected Metastatic Fracture."
Hanna Thompson discusses her CIO2023 abstract, "CIO 2023-30 Palliative Ablation and Kyphoplasty for a Suspected Metastatic Fracture."
Hanna Thompson discusses her...
11/30/2023
IO Learning
Thyroid Ablation after Thyroid Cancer Recurrence in a Hostile Neck
CIO2023 Highlights
Thyroid Ablation After Thyroid Cancer Recurrence in a Hostile Neck
11/30/2023
Hanna Thompson discusses her CIO2023 abstract, "CIO 2023-31 Thyroid Ablation after Thyroid Cancer Recurrence in a Hostile Neck ."
Hanna Thompson discusses her CIO2023 abstract, "CIO 2023-31 Thyroid Ablation after Thyroid Cancer Recurrence in a Hostile Neck ."
Hanna Thompson discusses her...
11/30/2023
IO Learning
Concurrent Liver Ablation and Paracentesis in Patients with Preexisting Ascites
CIO2023 Highlights
Concurrent Liver Ablation and Paracentesis in Patients with Preexisting Ascites
11/30/2023
Hanna Thompson discusses her CIO2023 abstract, "Concurrent Liver Ablation and Paracentesis in Patients with Preexisting Ascites."
Hanna Thompson discusses her CIO2023 abstract, "Concurrent Liver Ablation and Paracentesis in Patients with Preexisting Ascites."
Hanna Thompson discusses her...
11/30/2023
IO Learning
Brendan Ryu
CIO2023 Highlights
Efficacy and Safety of Intraarterial Chemotherapy in Locally Aggressive Breast Cancers: A 10-Year Literature Review
11/14/2023
Brendan Ryu discusses his CIO2023 abstract, "CIO 2023-23 Efficacy and Safety of Intraarterial Chemotherapy in Locally Aggressive Breast Cancers: A 10-Year Literature Review ."
Brendan Ryu discusses his CIO2023 abstract, "CIO 2023-23 Efficacy and Safety of Intraarterial Chemotherapy in Locally Aggressive Breast Cancers: A 10-Year Literature Review ."
Brendan Ryu discusses his...
11/14/2023
IO Learning
Ashwin Mahendra
CIO2023 Highlights
Percutaneous Ablation of Colorectal Liver Metastasis in a Patient With Hereditary Hemorrhagic Telangiectasia
11/13/2023
Ashwin Mahendra discusses his CIO2023 abstract, "CIO 2023-35 Percutaneous Ablation of Colorectal Liver Metastasis in a Patient With Hereditary Hemorrhagic Telangiectasia."
Ashwin Mahendra discusses his CIO2023 abstract, "CIO 2023-35 Percutaneous Ablation of Colorectal Liver Metastasis in a Patient With Hereditary Hemorrhagic Telangiectasia."
Ashwin Mahendra discusses his...
11/13/2023
IO Learning
CIO 2023-34 Radioembolization Plus Gemcitabine, Cisplatin, and Capecitabine as First-Line Therapy for Intrahepatic Cholangiocarcinoma
Purpose: To report outcomes of an institutional downstaging protocol for intrahepatic cholangiocarcinoma (iCCA) using radioembolization (TARE), gemcitabine, cisplatin, and capecitabine co...
11/02/2023
CIO 2023-33 Tumor Size and Watershed Area Correlates in Progression of Hepatocellular Carcinoma after Segmental Radioembolization
Purpose: To identify factors of incomplete treatment after segmental transarterial radioembolization (TARE) for treatment-naïve and solitary hepatocellular carcinoma (HCC)
11/02/2023
CIO 2023-32 Transradial versus Transfemoral Access for Interventional Oncology Procedures: A Systematic Review and Meta-Analysis
Purpose: The procedural and clinical outcomes of a transradial approach (TRA) versus a transfemoral approach (TFA) for interventional oncology (IO) procedures remain unclear.
11/02/2023
CIO 2023-26 The Cost of Catheter Dislodgement
Purpose: Long term care of patient's with complicated disease processes often incurs significant financial burden. This burden if often complicated with misuse or failure of medical devic...
11/02/2023

Interviews

Constantino Peña, MD, Miami Cancer Institute
Videos
The Importance of a Multidisciplinary Approach in Interventional Oncology
03/21/2024

Featuring Constantino Peña, MD

Featuring Constantino Peña, MD ...
Constantino Peña, MD, discusses the importance of a multidisciplinary approach within the field of interventional oncology.
Constantino Peña, MD, discusses the importance of a multidisciplinary approach within the field of interventional oncology.
Constantino Peña, MD, discusses...
03/21/2024
IO Learning
Dr. David Breen and Dr. Maxine Tran
Video
Partnership of Interventional Radiology and Urology in the Treatment of RCC
09/01/2023
Dr. Maxine Tran and Dr. David Breen discuss the partnership of interventional radiology and urology in the treatment of RCC. Some of the topics of specific interest are the collaboration between urologists and interventional radiologists,...
Dr. Maxine Tran and Dr. David Breen discuss the partnership of interventional radiology and urology in the treatment of RCC. Some of the topics of specific interest are the collaboration between urologists and interventional radiologists,...
Dr. Maxine Tran and Dr. David...
09/01/2023
IO Learning
Dr. Solomon Dr. Elsayed Future of IO
Interview
The Future of IO: Embracing the ‘Pioneer Spirit’ of Innovative Cancer Care
08/22/2023
The interventional oncology field is one that is ever-expanding and bringing fresh perspectives and innovative solutions for cancer care to the forefront of the health industry. IO Learning recently interviewed  Mohammad Elsayed, MD,...
The interventional oncology field is one that is ever-expanding and bringing fresh perspectives and innovative solutions for cancer care to the forefront of the health industry. IO Learning recently interviewed  Mohammad Elsayed, MD,...
The interventional oncology...
08/22/2023
IO Learning
Interview
Phase I First-in-Human Study on the Use of Embrace Liquid Embolic for the Treatment of Hypervascular Tumors
06/14/2022
IO Learning spoke with Gerard S. Goh, MBBS, co-investigator of a recent pilot study on the Embrace Hydrogel Embolic System for the treatment of benign and malignant hypervascular tumors.
IO Learning spoke with Gerard S. Goh, MBBS, co-investigator of a recent pilot study on the Embrace Hydrogel Embolic System for the treatment of benign and malignant hypervascular tumors.
IO Learning spoke with Gerard S....
06/14/2022
IO Learning
Dr Tomkovich
Podcasts
Interview With Dr Kenneth Tomkovich: ICE3 Trial 3-Year Interim Results
10/20/2021
The ICE3 trial was designed to evaluate the safety and efficacy of breast cryoablation in women older than 60 years with low-risk early-stage breast cancers. Dr Kenneth Tomkovich, co-principal investigator of ICE3, joined us to discuss the...
The ICE3 trial was designed to evaluate the safety and efficacy of breast cryoablation in women older than 60 years with low-risk early-stage breast cancers. Dr Kenneth Tomkovich, co-principal investigator of ICE3, joined us to discuss the...
The ICE3 trial was designed to...
10/20/2021
IO Learning
Dr Edward Kim
Sponsored Interview
Upgrading Interventional Labs to Improve Workflow and Efficiency at Mount Sinai Health System
10/17/2024
Edward Kim, MD, from Mount Sinai Health System, recently shared his views on replacing his aging imaging equipment to improve the efficiency of the interventional radiology suite at Mount Sinai.
Edward Kim, MD, from Mount Sinai Health System, recently shared his views on replacing his aging imaging equipment to improve the efficiency of the interventional radiology suite at Mount Sinai.
Edward Kim, MD, from Mount Sinai...
10/17/2024
Vascular Disease Management
Q&As
Compliance With Interventional Oncology Accreditation Standards Among Interventional Radiologists
03/25/2024

Featuring Murat Dökdök, MD

Featuring Murat Dökdök, MD
Dr Murat Dökdök discusses the importance of compliance with interventional oncology accreditation standards among interventional radiologists.
Dr Murat Dökdök discusses the importance of compliance with interventional oncology accreditation standards among interventional radiologists.
Dr Murat Dökdök discusses the...
03/25/2024
IO Learning
Constantino Peña, MD, Miami Cancer Institute
Videos
The Importance of a Multidisciplinary Approach in Interventional Oncology
03/21/2024

Featuring Constantino Peña, MD

Featuring Constantino Peña, MD ...
Constantino Peña, MD, discusses the importance of a multidisciplinary approach within the field of interventional oncology.
Constantino Peña, MD, discusses the importance of a multidisciplinary approach within the field of interventional oncology.
Constantino Peña, MD, discusses...
03/21/2024
IO Learning
Jack Jennings, MD, PhD, Washington University in St Louis
Videos
Treatment of Primary and Metastatic Sarcoma
02/06/2024
At the 2024 SIO Annual Meeting, Jack Jennings, MD, PhD, discussed the role of the interventional oncologist when treating primary or metastatic sarcomas of the bone or soft tissue.
At the 2024 SIO Annual Meeting, Jack Jennings, MD, PhD, discussed the role of the interventional oncologist when treating primary or metastatic sarcomas of the bone or soft tissue.
At the 2024 SIO Annual Meeting,...
02/06/2024
IO Learning
Riccardo Lencioni, MD, University of Pisa School of Medicine
Videos
Addition of Durvalumab, Bevacizumab to TACE for Hepatocellular Carcinoma Improves PFS
01/23/2024
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares...
01/23/2024
Oncology
Managing Y90 to the GI Tract with Dr. Oleksandra Kutsenko
Interview
Managing Y90 to the GI Tract with Dr. Oleksandra Kutsenko
12/08/2023
In this brief interview, Oleksandra Kutsenko, MD at Red Rock Radiology Associates, shares how she successfully manages Y90 to the GI tract.
In this brief interview, Oleksandra Kutsenko, MD at Red Rock Radiology Associates, shares how she successfully manages Y90 to the GI tract.
In this brief interview,...
12/08/2023
IO Learning
Dr. Riad Salem
Interview
Redefining the ‘Status Quo’ of IO
12/07/2023
In this interview with Riad Salem, MD, Chief of Vascular and Interventional Radiology in the Department of Radiology at Northwestern Medicine, we discuss the future of IO, unique approaches to Y-90, and what's next for the interventional...
In this interview with Riad Salem, MD, Chief of Vascular and Interventional Radiology in the Department of Radiology at Northwestern Medicine, we discuss the future of IO, unique approaches to Y-90, and what's next for the interventional...
In this interview with Riad...
12/07/2023
IO Learning
Dr. Edward Kim
CIO2023 Highlights
HCC, Flow-Diversion, and IO Outpatient Labs with Dr. Edward Kim
12/06/2023
In this interview feature, Dr. Edward Kim discusses HCC highlights, flow-diversion techniques, and running an outpatient IO lab.
In this interview feature, Dr. Edward Kim discusses HCC highlights, flow-diversion techniques, and running an outpatient IO lab.
In this interview feature, Dr....
12/06/2023
IO Learning
Dr. AJ Gunn Unmasked
Interview
IO ‘Unmasked’: An Interview With Dr. AJ Gunn
11/07/2023
In this interview, Dr. AJ Gunn shares insights and lessons about his profession and passions.
In this interview, Dr. AJ Gunn shares insights and lessons about his profession and passions.
In this interview, Dr. AJ Gunn...
11/07/2023
IO Learning
Dr. Ripal Gandhi HCC
Interview
Locoregional Therapies and High Lung Shunts: An HCC Highlight With Dr. Ripal Gandhi
10/25/2023
Dr. Ripal Gandhi, MD, FSVM, discusses locoregional therapies for the treatment of HCC as well as high lung shunt management for HCC patients.
Dr. Ripal Gandhi, MD, FSVM, discusses locoregional therapies for the treatment of HCC as well as high lung shunt management for HCC patients.
Dr. Ripal Gandhi, MD, FSVM,...
10/25/2023
IO Learning

Subscribe

IO Learning Newsletter

News

News
Novel Endovascular Robotic Surgical System Reaches Midpoint of Pivotal Clinical Trial
09/20/2024
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY®...
09/20/2024
IO Learning
News
Histotripsy Demonstrates Technical Success, Safety for Primary and Metastatic Liver Tumors
09/04/2024
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the...
09/04/2024
IO Learning
News
Immunophotonics Announces 1st Patient Dosed in Multinational Clinical Trial in the United Kingdom
06/02/2023
Saint Louis, MO | Bern, Switzerland (2 June 2023) — Immunophotonics Inc., a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs, has announced the recruitment and the dosing of its first...
Saint Louis, MO | Bern, Switzerland (2 June 2023) — Immunophotonics Inc., a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs, has announced the recruitment and the dosing of its first...
Saint Louis, MO | Bern,...
06/02/2023
IO Learning
News
The Future of Bleeding Control: Obsidio Conformable Embolic
05/22/2023
Marlborough, MA (17 May 2023) –Suppose you’re a doctor who needs to stop blood flow in a patient. Maybe it’s a patient with internal bleeding after an accident. Perhaps it’s to starve the blood supply of a patient’s cancerous tumor...
Marlborough, MA (17 May 2023) –Suppose you’re a doctor who needs to stop blood flow in a patient. Maybe it’s a patient with internal bleeding after an accident. Perhaps it’s to starve the blood supply of a patient’s cancerous tumor...
Marlborough, MA (17 May...
05/22/2023
IO Learning
News
Study Shows Promising Safety, Patient Outcomes Data for MRI-Guided Adaptive Radiation Therapy to Treat Pancreatic Cancer
11/21/2022
DETROIT (Nov. 21, 2022) – Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic MRI-Guided On-table...
DETROIT (Nov. 21, 2022) – Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic MRI-Guided On-table...
DETROIT (Nov. 21, 2022) –...
11/21/2022
IO Learning
News
New Liquid Embolic Multi-Center Trial Successfully Enrolls Final Patient
09/01/2022
GPX® Trial Completes Enrollment Demonstrating Successful Tumor Uses and Other Applications
GPX® Trial Completes Enrollment Demonstrating Successful Tumor Uses and Other Applications
GPX® Trial Completes Enrollment...
09/01/2022
IO Learning
News
HistoSonics Hits Pivotal Clinical Trial Milestone In #HOPE4LIVER Studies
06/03/2022
Company Continues to Build as It Prepares for FDA Submission and Clearance of Its Breakthrough Therapy
Company Continues to Build as It Prepares for FDA Submission and Clearance of Its Breakthrough Therapy
Company Continues to Build as It...
06/03/2022
IO Learning
News
Novel Endovascular Robotic Surgical System Reaches Midpoint of Pivotal Clinical Trial
09/20/2024
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY®...
09/20/2024
IO Learning
News
Histotripsy Demonstrates Technical Success, Safety for Primary and Metastatic Liver Tumors
09/04/2024
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the...
09/04/2024
IO Learning
News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement